Computational insights into the inhibitory effects of PFAS 14 on colorectal cancer targeting GSTA1 through

Jinxiao Li1, Yanran Wu2, Pian Ye3

  • 1Department of Clinical Nutrition, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1227 Jiefang Avenue, Wuhan Hubei, 430022, China.

Insights

Per- and polyfluoroalkyl substances (PFAS) may impact colorectal cancer (CRC) by interacting with key proteins like glutathione S-transferase A1 (GSTA1). PFAS 14 specifically binds to GSTA1, potentially inhibiting its function and affecting cancer progression.

Area of Science:

  • Environmental Health
  • Computational Biology
  • Oncology

Background:

  • Per- and polyfluoroalkyl substances (PFAS) are environmental contaminants with potential health implications.
  • Glutathione S-transferase A1 (GSTA1) is crucial for detoxification and its dysregulation is linked to colorectal cancer (CRC) progression and chemoresistance.

Purpose of the Study:

  • To investigate the molecular interactions between PFAS and key colorectal cancer (CRC) proteins using computational methods.
  • To identify specific PFAS compounds and their binding affinities to potential CRC-related protein targets.

Main Methods:

  • Employed computational biology approaches, including molecular docking and simulations.
  • Analyzed the binding affinity and stability of PFAS compounds with target proteins, focusing on GSTA1.

Main Results:

  • PFAS compounds show potential to modulate multiple CRC proteins, with a notable interaction with GSTA1.
  • PFAS 14 demonstrated high binding affinity for GSTA1, specifically targeting its glutathione-binding site.
  • Simulations confirmed stable binding of PFAS 14 to GSTA1, suggesting a potential inhibitory mechanism.

Conclusions:

  • GSTA1 is identified as a key protein target for PFAS interactions in the context of colorectal cancer.
  • Environmental PFAS exposure may influence CRC by interfering with GSTA1-mediated detoxification pathways.
  • PFAS 14's potential as a competitive inhibitor of GSTA1 warrants further experimental investigation for its effects on cancer cell survival and progression.